Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 5:00 AM
Ignite Modification Date:
2025-12-25 @ 5:00 AM
NCT ID:
NCT02467218
Eligibility Criteria:
Inclusion Criteria:
* Function Improvement Questionnaire (Revised) score ≥ 60 during the baseline assessment.
Exclusion Criteria:
* Women with positive pregnancy test or plans to become pregnant during the study period
* Claustrophobia
* Seizure disorder
* Active asthma
* Severe chronic obstructive pulmonary disease
* Previous thoracic surgery
* History of pneumothorax
* History of severe congestive heart failure with left ventricular ejection fraction \< 30%
* Unstable angina
* Chronic sinusitis
* Chronic or acute otitis media or major ear drum trauma
* Current treatment with bleomycin, cisplatin, doxorubicin and disulfiram
* Participation in another investigative drug or device trial currently or within the last 30 days
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02467218
Study Brief:
Protocol Section:
NCT02467218